Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: The effects on postoperative bleeding and volume expansion needs after elective CABG

Acta Anaesthesiologica Belgica

Volumn 60, Issue 2, 2009, Pages 91-97

  Vanhoonacker, J ^a   Ongenae, Marc ^b   Vanoverschelde, H ^b   Donadoni, R ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b AZ Maria Middelares   (Belgium)

Author keywords

CABG; Cardiopulmonary bypass; Gelatine; Hydroxyethyl starch; Postoperative bleeding

Indexed keywords

ACETYLSALICYLIC ACID; CISATRACURIUM; FRESH FROZEN PLASMA; GELATIN; GELOPLASMA; HEPARIN; HETASTARCH; HUMAN ALBUMIN; PROPOFOL; PROTAMINE; REMIFENTANIL; SEVOFLURANE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SAFETY; THORAX DRAINAGE; THROMBOCYTE TRANSFUSION;

AGED; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; GELATIN; HETASTARCH; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE;

EID: 67650818489     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Boldt J., Brenner T., Lehmann A., et al., Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery : comparison of new starch preparation with gelatin, INTENSIVE CARE MED., 29, 763-769, 2003.
2. Chong Sung K., Pum Suk P., Mi Ja Y., Kyoung Ok K., Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery : a randomized clinical trial, ACTA ANAESTHESIOL. SCAND., 50, 108-111, 2006.
3. Franz A., Bräunlich P., Gamsjäger T., et al., The effects of hydroxy-ethyl starches of varying molecular weighs on platelet function, ANESTH. ANALG., 92, 1402-1407, 2001.
4. Gallandat Huet R. C. G., Siemons A. W., Baus D., et al., A novel hydroxyethyl starch (Voluven) for effective peri-operative volume substitution in cardiac surgery, CAN. J. ANAESTH., 47, 1207-1215, 2000.
5. Jungheinrich C., Sauermann W., Bepperling F., Voght N. H., Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimized in vivo molecular weight in orthopaedic surgery, DRUGS R&D, 5, 1-9, 2004.
6. Knutson J. E., Deering J. A., Hall F. W., Nuttall G. A., Schroeder D. R., White R. D., Mullany C. J., Does intra- operative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery ?, ANESTH. ANALG., 90, 801-807, 2000.
7. Kozek-Langenecker S. A., Jungheinrich C., Sauermann W., Van der Linden P., The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery : a pooled analysis of randomized clinical trials, ANESTH. ANALG., 107, 382-390, 2008.
8. Langeron O., Doelberg M., Engl-Than A., et al., Voluven®, a lower substituted novel hydroxyethyl starch (HES 130/0.4) causes fewer effects on coagulation in major orthopaedic surgery than HES 200/0.5, ANESTH. ANALG., 92, 855-862, 2001.
9. Laxenaire M. C., Charpentier C., Feldman L., Anaphylactoid reactions to colloid plasma substitutes : incidence, risk factors, mechanisms : a French multicenter prospective study, ANN. FR. ANESTH. RÉANIM., 13, 301-310, 1994.
10. Mercuriali F., Inghilleri G., Proposal of an algorithm to help the choice of the best transfusion strategy, CURR. MED. RES. OPIN., 13, 465-478, 1996.
11. Stögermüller B., Stark J., Willschke H., et al., The effect of hydroxyethylstarch 200kD on platelet function, ANESTH. ANALG., 91, 823-827, 2000.
12. Strauss R. G., Pennel B. J., Stump D. C., A randomized blinded trial comparing the hemostatic effects of pentastarch versus hetastarch, TRANSFUSION, 42, 27-36, 2002.
13. Treib J., Baron J. F., Grauer M. T., Strauss R. G., An international view of hydroxyethyl starches, INTENSIVE CARE MED., 25, 258-268, 1999.
14. Van Der Linden P., De Hert S., Hydroxyethyl Starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients : the effects on perioperative bleeding and transfusion needs, ANESTH. ANALG., 101, 629-34, 2005.
15. Van der Linden P., De Hert S., 3.5% urea-linked gelatin is as effective as 6% HES200/.5 for volume management in cardiac surgery patients, CAN. J. ANAESTH., 51, 236-241, 2004.